Amylyx Pharmaceuticals, Inc. (AMLX)
37.18
+0.10
(+0.27%)
USD |
NASDAQ |
Aug 27, 16:00
36.79
-0.39
(-1.05%)
After-Hours: 20:00
Amylyx Pharmaceuticals EPS Diluted (TTM) : -1.433 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.433 |
| March 31, 2026 | -1.507 |
| December 31, 2025 | -1.553 |
| September 30, 2025 | -1.800 |
| June 30, 2025 | -2.499 |
| March 31, 2025 | -3.103 |
| December 31, 2024 | -4.434 |
| September 30, 2024 | -3.819 |
| June 30, 2024 | -2.451 |
| March 31, 2024 | -1.068 |
| December 31, 2023 | 0.7049 |
| September 30, 2023 | -0.0163 |
| Date | Value |
|---|---|
| June 30, 2023 | -1.234 |
| March 31, 2023 | -2.473 |
| December 31, 2022 | -3.322 |
| September 30, 2022 | -3.159 |
| June 30, 2022 | -2.650 |
| March 31, 2022 | -2.105 |
| December 31, 2021 | -1.529 |
| September 30, 2021 | -1.192 |
| June 30, 2021 | -0.782 |
| March 31, 2021 | -0.4032 |
| December 31, 2020 | -0.1522 |
| September 30, 2020 | 0.00 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Pfizer Inc. | 0.7552 |
| Eli Lilly & Co. | 29.43 |
| Merck & Co., Inc. | 1.251 |
| EyePoint, Inc. | -3.744 |
| Bristol Myers Squibb Co. | 4.539 |